RE:IIROC Report was positive = Increased productionMedMira has ramped up its weekly production within a short period of time and has substantially increased its existing and trained work force in order to meet the increasing demand for its product. The Company has started shipping REVEALCOVID-19™ Total Antibody Test, RVF®-based rapid serological assay that detects total antibodies to the SARS-CoV-2 virus, the causative agent of COVID-19, in human serum, plasma and venipuncture whole blood, to its exclusive distribution partner, WebbDX. MedMira is extremely pleased that, at the time of the ongoing COVID-19 crisis, the company could bring REVEALCOVID-19™ Total Antibody Test to the market as well as create new jobs.